A. Galbraith

Publication List Details

Period

1999 - 2007

Number

9

Co-Authors

Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure (2003)

Russell, F. D., Meyers, D. E., Galbraith, A., Bett, N., Toth, I., Kearns, P. S., ...

Human urotensin-II (hU-II) is the most potent endogenous cardiostimulant identified to date. We therefore determined whether hU-II has a possible pathological role by investigating its levels in...

Eosinophilic heart: Marked left ventricular wall thickening and myocardial dysfunction improving with corticosteroid therapy (2003)

Adsett, M, West, MJ, Galbraith, A, Duhig, E, Lange, A, Palka, P

We report a case of a 34-year-old male with acute severe heart failure associated with marked concentric left ventricular wall thickening and biopsy evidence of eosinophilic myocardial infiltrate....

Activation and adoptive transfer of Epstein-Barr virus-specific cytotoxic T cells in solid organ transplant patients with posttransplant lymphoproliferative disease (1999)

Khanna, R., Bell, S., Sherritt, M., Galbraith, A., Burrows, S. R., Rafter, L., ...

The treatment of Epstein-Barr virus (EBV)associated lymphoproliferative disease (PTLD) in EBV seronegative solid organ transplant recipients who acquire their EBV infection after engraftment poses a...

Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure (1999)

Watson, P. S., Scalia, G. M., Galbraith, A., Burstow, D. J., Bett, N., Aroney, C. N.

OBJECTIVES This study evaluated the effects of oral therapy with coenzyme Q on echocardiographic and hemodynamic indexes of left ventricular function and on quality of life in patients with chronic...